Furthermore, while the inactivation of epithelial-specific IL-1R1 resulted in a decrease in CRC burden, a similar knockdown of IL-1R1 in myeloid cells enhanced tumor growth. The gene discussed is IL1R1; the disease is colorectal carcinoma.